Mesoporous silica nanoparticles in nanotechnology

Critical Reviews in Biotechnology

Volumn 33, Issue 3, 2013, Pages 229-245

  Douroumis, Dennis ^a   Onyesom, Ichioma ^a   Maniruzzaman, Mohammed ^a   Mitchell, John ^a  

^a UNIVERSITY OF GREENWICH   (United Kingdom)

Author keywords

Biocompatibility; Cytotoxicity; Drug delivery; Functionalization; Mesoporous silica nanoparticles

Indexed keywords

ANTI-CANCER AGENTS; DRUG DELIVERY SYSTEM; FUNCTIONALIZATIONS; GENETIC MATERIALS; GUEST MOLECULES; MESOPOROUS SILICA NANOPARTICLES; SURFACE FUNCTIONALIZATION; SYNTHESIS METHOD;

BIOCOMPATIBILITY; CYTOTOXICITY; PROTEINS;

DRUG DELIVERY;

ALENDRONIC ACID; AMOXICILLIN; CAMPTOTHECIN; CAPTOPRIL; CISPLATIN; DOXORUBICIN; FLUORESCEIN ISOTHIOCYANATE; IBUPROFEN; IRINOTECAN; MESOPOROUS SILICA NANOPARTICLE; NANOCARRIER; NANOPARTICLE; PACLITAXEL; SILICON DIOXIDE; SURFACTANT; UNCLASSIFIED DRUG;

ADSORPTION; ANTINEOPLASTIC ACTIVITY; AQUEOUS SOLUTION; BIOCOMPATIBILITY; BIOSENSOR; BLEACHING; BREAST CANCER; CATALYSIS; CHEMICAL COMPOSITION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; FLUORESCENCE ANALYSIS; HUMAN; HYDROLYSIS; INTERNALIZATION; LIQUID CRYSTAL; MICELLE; MICROEMULSION; NANOTECHNOLOGY; NONHUMAN; PARTICLE SIZE; POROSITY; PRIORITY JOURNAL; REVIEW; SURFACE PROPERTY; SUSTAINED DRUG RELEASE; SYNTHESIS;

ANIMALS; DRUG CARRIERS; HUMANS; NANOPARTICLES; NANOTECHNOLOGY; SILICON DIOXIDE;

EID: 84881124752     PISSN: 07388551     EISSN: 15497801     Source Type: Journal    
DOI: 10.3109/07388551.2012.685860     Document Type: Review

References (114)

1. Ambrogio MW, Thomas CR, Zhao YL, Zink JI, Stoddart JF. 2011. Mechanized silica nanoparticles: a new frontier in theranostic nanomedicine. Acc Chem Res 44: 903-913.
2. Andersson J, Rosenholm J, Areva S, Linden M. 2004. Influences of material characteristics on ibuprofen drug loading and release profiles from ordered micro- and mesoporous silica matrices. Chem Mater 16: 4160-4167.
3. Attard GS, Glyde JC, Goeltner CG. 1995. Liquid-crystalline phases as templates for the synthesis of mesoporous silica. Nature 378: 366.
4. Azais T, TournQ-PQteilh C, Aussenac F, Baccile N, Coelho C, Devoisselle JM, Babonneau F. 2006. Solid-state nmr study of ibuprofen confined in mcm-41 material. Chem Mater 18: 6382-6390.
5. Bagshaw SA, Pinnavaia TJ. 1996. Mesoporous alumina molecular sieves. Angew Chem Int Ed Engl 35: 1102.
6. Bagshaw SA, Prouzet E, Pinnavaia TJ. 1995. Templating of mesoporous molecular sieves by nonionic polyethylene oxide surfactants. Science 269: 1242-1244.
7. Bagwe RP, Hilliard LR, Tan W. 2006. Surface modification of silica nanoparticles to reduce aggregation and nonspecific binding. Langmuir 22: 4357-4362.
8. Bagwe RP, Yang C, Hilliard LR, Tan W. 2004. Optimization of dye-doped silica nanoparticles prepared using a reverse microemulsion method. Langmuir 20: 8336-8342.
9. Balas F, Manzano M, Horcajada P, Vallet-Regí M. 2006. Confinement and controlled release of bisphosphonates on ordered mesoporous silica-based materials. J Am Chem Soc 128: 8116-8117.
10. Beck JS, Vartuli JC, Roth WJ, Leonowicz ME. Kresge CT, Schmitt KD, Chu CTW, Olson D, Sheppard EW, Mccullen SB, Higgins JB, Schlenkert JL. 1992. A new family of mesoporous molecular sieves prepared with liquid crystals templates. Am Chem Soc 114: 10834-10843.
11. Bharali DJ, Klejbor I, Stachowiak EK, Dutta P, Roy I et al. 2005. Organically modified silicananoparticles: A nonviral vector for in vivo gene delivery and expression in the brain. Nat Acad Sci 102: 11539-11544.
12. Botella P, Abasolo I, Fernández Y, Muniesa C, Miranda S, Quesada M, Ruiz J, Schwartz S Jr, Corma A. 2011. Surface-modified silica nanoparticles for tumor-targeted delivery of camptothecin and its biological evaluation. J Control Release 156: 246-257.
13. Burns A, Ow H, Wiesner U. 2006. Fluorescent core-shell silica nanoparticles: towards "Lab on a Particle" architectures for nanobiotechnology. Chem Soc Rev 35: 1028-1042.
14. Cagnol F, Grosso D, Sanchez C. 2004. A general one-pot process leading to highly functionalised ordered mesoporous silica films. Chem Commun (Camb): 1742-1743.
15. Casasús R, Marcos MD, Martínez-Máñez R, Ros-Lis JV, Soto J, Villaescusa LA, Amorós P, Beltrán D, Guillem C, Latorre J. 2004. Toward the development of ionically controlled nanoscopic molecular gates. J Am Chem Soc 126: 8612-8613.
16. Chang et al. 2010. Surface functionalisation of magnetic mesoporous silica nanoparticles for controlled drug release. J Mater Chem 20: 9941-9947.
17. Che S, Garcia-Bennett AE, Liu X. 2003. Synthesis of large-pore ia3d mesoporous silica. Angew Chem Int 42: 3930-3934.
18. Chen AM, Zhang M, Wei D, Stueber D, Taratula O, Minko T, He H. 2009. Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells. Small 5: 2673-2677.
19. Chen CC, Do JS, Gu Y. 2009. Immobilization of HRP in Mesoporous Silica and Its Application for the Construction of Polyaniline Modified Hydrogen Peroxide Biosensor. Sensors (Basel) 9: 4635-4648.
20. Cho EB, Volkov DO, Sokolov I. 2010. Ultrabright fluorescent mesoporous silica nanoparticles. Small 6: 2314-2319.
21. Cho et al. 2008. Functionalised mesoporous silica nanoparticles based drug delivery system to rescue acrolein cell mediated death. Nanomedicine 3: 507-519.
22. Chung TH, Wu SH, Yao M, Lu CW, Lin YS, Hung Y, Mou CY, Chen YC, Huang DM. 2007. The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells. Biomaterials 28: 2959-2966.
23. Das S, Jain TK, Maitra A. 2002. Inorganic-organic hybrid nanoparticles from n-octyl triethoxy silane. J Colloid Interface Sci 252: 82-88.
24. Deng G, Markowitz M, Kust P, Gaber GP. 2000. Control of surface expression of functional groups on silica particles. Mater Sci Eng 11: 65-172.
25. Dey RK, Oliveira FJVE, Airoldi C. 2008. Mesoporous silica functionalized with diethylenetriamine moieties for metal removal and thermodynamics of cation-basic center interactions. Colloids and Surfaces A: Physicochem Eng Aspects 324: 41-46.
26. Di Pasqua AJ, Sharma KK, Shi YL, Toms BB, Ouellette W, Dabrowiak JC, Asefa T. 2008. Cytotoxicity of mesoporous silica nanomaterials. J Inorg Biochem 102: 1416-1423.
27. Doadrio JC, Sousa EMB, Izquierdo-Barba I et al. 2006. Functionalization of mesoporous materials with long alkyl chains as a strategy for controlling drug delivery pattern. J Mater Chem 16: 462-467.
28. Fan J, Yu C, Gao F, Lei J, Tian B, Wang L, Luo Q, Tu B, Zhou W, Zhao D. 2003. Cubic Mesoporous Silica with Large Controllable Entrance Sizes and Advanced Adsorption Properties. Angew Chem 115: 3254-3258.
29. Fisichella M, Dabboue H, Bhattacharyya S, Lelong G, Saboungi ML, Warmont F, Midoux P, Pichon C, Guérin M, Hevor T, Salvetat JP. 2010. Uptake of functionalized mesoporous silica nanoparticles by human cancer cells. J Nanosci Nanotechnol 10: 2314-2324.
30. Giri S, Trewyn BG, Stellmaker MP, Lin VSY. 2005. Stimuli-responsive controlled-release delivery system based on mesporous silica nanorods capped with magnetic nanoparticles. Angew Chem Int Ed 44: 5038.
31. Gruenhagen JA, Lai CY, Radu DR, Lin VS, Yeung ES. 2005. Real-time imaging of tunable adenosine 5-triphosphate release from an MCM-41-type mesoporous silica nanosphere-based delivery system. Appl Spectrosc 59: 424-431.
32. Guzman et al. 2006. Environmental risks of nanotechnology:national nanotechnology initiative funding. Environ Sci Technol 40: 1401-1407.
33. Ha SW, Camalier CE, Beck GR Jr, Lee JK. 2009. New method to prepare very stable and biocompatible fluorescent silica nanoparticles. Chem Commun (Camb): 2881-2883.
34. Han L, Sakamoto Y, Terasaki O, Li Y, Che S. 2006. Synthesis of carboxylic group functionalized mesoporous silicas (CFMSs) with various structures. J Mater Chem 17: 1216-1221.
35. Hata H, Saeki S, Kimura T, Sugahara Y, Kuroda K. 1999. Absorption of taxol into ordered mesoporous silica with various pore diameters. Chem Mater 11: 1110-1119.
36. He Q, Shi J, Chen F, Zhu M, Zhang L. 2010. An anticancer drug delivery system based on surfactant-templated mesoporous silica nanoparticles. Biomaterials 31: 3335-3346.
37. He Q, Zhang Z, Gao Y, Shi J, Li Y. 2009. Intracellular localization and cytotoxicity of spherical mesoporous silica nano- and microparticles. Small 5: 2722-2729.
38. Hernandez R, Tseng HR, Wong JW, Stoddart JF, Zink JI. 2004. An operational. supramolecular nanovalve. J Am Chem Soc 126: 3370-3371.
39. Holmes JD, Lyons DM, Ziegler KJ. 2003. Supercritical fluid synthesis of metal and semiconductor nanomaterials. Chem Eur J 9:2144-2150.
40. Horcajada A, Ramila A, Perez-Pariente J, Vallet-Regi M. 2004, 2006. Influence of pore size of MCM-41 matrices on drug delivery rate. Micropor Mesopor Mater 68: 105-109.
41. Hoshikawa Y, Yabe H, Nomura A, Yamaki T, Shimojima A, Okubo T. 2010. Mesoporous silica nanoparticles with remarkable stability and dispersibility for antireflective coatings. Chem Mater 22: 12-14.
42. Huang IP, Sun SP, Cheng SH, Lee CH, Wu CY, Yang CS, Lo LW, Lai YK. 2011. Enhanced chemotherapy of cancer using pH-sensitive mesoporous silica nanoparticles to antagonize P-glycoproteinmediated drug resistance. Mol Cancer Ther 10: 761-769.
43. Huo Q, Margolese DI, Ciesla U, Demuth DG, Feng P, Gier TE, Sieger P et al. 1994. Rapid synthesis of mesoporous silica with micrometer sized hexagonal prism structure. Chem Mater 6: 1176.
44. Jain TK, Roy I, De TK, Maitra A. 1998. Nanometer silica particles encapsulating active compounds: A novel ceramic drug carrier. J Am Chem Soc 120: 11092-11095.
45. Jeon YH, Kim YH, Choi K, Piao JY, Quan B, Lee YS, Jeong JM, Chung JK, Lee DS, Lee MC, Lee J, Chung DS, Kang KW. 2010. In vivo imaging of sentinel nodes using fluorescent silica nanoparticles in living mice. Mol Imaging Biol 12: 155-162.
46. Kim H, Kim S, Park C, Lee H, Park HJ, Kim C. 2010. Glutathioneinduced intracellular release of guests from mesoporous silica nanocontainers with cyclodextrin gatekeepers. Adv Mater 22: 4280-4283.
47. Kim HK et al. 1999. Highly efficient organic/inorganic hybrid nonlinear optic materials via sol-gel process: synthesis, optical properties, and photobleaching for channel waveguides. Chem Mater 11: 779-788.
48. Knopp D, Tang D, Niessner R. 2009. Review: bioanalytical applications of biomolecule-functionalized nanometer-sized doped silica particles. Anal Chim Acta 647: 14-30.
49. Kresge CT, Leonowicz ME, Roth WJ, Vartuli JC, Beck JS. 1992. Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism. Nature (London) 359: 710-771.
50. Lai CY, Trewyn BG, Jeftinija DM, Jeftinija K, Xu S, Jeftinija S, Lin VS. 2003. A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuliresponsive controlled release of neurotransmitters and drug molecules. J Am Chem Soc 125: 4451-4459.
51. Lee CH, Cheng SH, Huang IP, Souris JS, Yang CS, Mou CY, Lo LW. 2010. Intracellular pH-responsive mesoporous silica nanoparticles for the controlled release of anticancer chemotherapeutics. Angew Chem Int Ed Engl 49: 8214-8219.
52. Lee H, Kim S, Choi BH, Park MT, Lee J, Jeong SY, Choi EK, Lim BU, Kim C, Park HJ. 2011. Hyperthermia improves therapeutic efficacy of doxorubicin carried by mesoporous silica nanocontainers in human lung cancer cells. Int J Hyperthermia 27: 698-707.
53. Lee J, Lee J, Kim S, Kim C, Lee S, Min B, Shin Y, Kim C. 2011. Sugarinduced release of guests from silica nanocontainer with cyclodextrin gatekeepers. Bull Korean Chem Soc 32: 1357-1360.
54. Li et al. 2011. Immobilization of glucose oxidase and platinum on mesoporous silica nanoparticles for the fabrication of glucose biosensor. Electrochimica Acta 56: 2960-2965.
55. Lin YS, Haynes CL. 2009. Synthesis and characterization of biocompatible and size-tunable multifunctional porous silica nanoparticles. Chem Mater 21, 3979-3986.
56. Lin YS, Tsai CP, Huang HY, Kuo CT, Hung Y, Huang DM, Chen Y-C, Mou CY. 2005. Well-ordered mesoporous silica nanoparticles as cell markers. Chem Mater 17: 4570-4573.
57. Liu R, Liao P, Liu J, Feng P. 2011. Responsive polymer-coated mesoporous silica as a pH-sensitive nanocarrier for controlled release. Langmuir 27: 3095-3099.
58. Lu J, Liong M, Sherman S, Xia T, Kovochich M, Nel AE, Zink JI, Tamanoi F. 2007. Mesoporous silica nanoparticles for cancer therapy: energy-dependent cellular uptake and delivery of paclitaxel to cancer cells. Nanobiotechnology 3: 89-95.
59. Lu J, Li Z, Zink JI, Tamanoi F. 2012. In vivo tumor suppression efficacy of mesoporous silica nanoparticles-based drug-delivery system: enhanced efficacy by folate modification. Nanomedicine: Nanotechnology, Biology, and Medicine 8: 212-220.
60. Lu J, Liong M, Li Z, Zink JI, Tamanoi F. 2010. Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. Small 6: 1794-1805.
61. Ma Y, Xing L, Zheng H, Che S. 2011. Anionic-cationic switchable amphoteric monodisperse mesoporous silica nanoparticles. Langmuir 27: 517-520.
62. Mal K, Fujiwara M, Tanaka Y, Taguchi T, Matsukata M. 2003. Photoswitched storage and release of guest molecules in the pore void of coumarin-modified mcm-41. Chem Mater 15: 3385-3339.
63. Manzano M, Balas F, Civantos A, Vallet-Regi M. 2006. Proceedings of the 20th European Conference on Biomaterials, Nantes.
64. Meng H, Xue M, Xia T, Ji Z, Tarn DY, Zink JI, Nel AE. 2011. Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model. ACS Nano 5: 4131-4144.
65. Morelli C, Maris P, Sisci D, Perrotta E, Brunelli E, Perrotta I, Panno ML, Tagarelli A, Versace C, Casula MF, Testa F, Andò S, Nagy JB, Pasqua L. 2011. PEG-templated mesoporous silica nanoparticles exclusively target cancer cells. Nanoscale 3: 3198-3207.
66. Muhammad F, Guo M, Qi W, Sun F, Wang A, Guo Y, Zhu G. 2011. pH-Triggered controlled drug release from mesoporous silica nanoparticles via intracelluar dissolution of ZnO nanolids. J Am Chem Soc 133: 8778-8781.
67. Mumin AM, Barrett JW, Dekaban GA, Zhang J. 2011. Dendritic cell internalization of foam-structured fluorescent mesoporous silica nanoparticles. J Colloid Interface Sci 353: 156-162.
68. Napierska D, Thomassen LC, Rabolli V, Lison D, Gonzalez L, Kirsch-Volders M, Martens JA, Hoet PH. 2009. Size-dependent cytotoxicity of monodisperse silica nanoparticles in human endothelial cells. Small 5: 846-853.
69. Nguyen TD, Liu Y, Saha S, Leung KC, Stoddart JF, Zink JI. 2007. Design and optimization of molecular nanovalves based on redoxswitchable bistable rotaxanes. J Am Chem Soc 129: 626-634.
70. Oye G, Sjöblom J, Stöcker M. 2001. Synthesis, characterization and potential applications of new materials in the mesoporous range. Adv Colloid Interface Sci 89-90: 439-466.
71. Pandya PH, Jasra RV, Newalkar BL, Bhatt PN. 2005. Studies on the activity and stability of immobilized alpha-amylase in ordered mesoporous silicas. Micro Meso Mater 17: 4577-4593.
72. Qhobosheane M, Santra S, Zhang P, Tan W. 2001. Biochemically functionalized silica nanoparticles. Analyst 126: 1274-1278.
73. Qu F, Zhu G, Huang S, Li S, Sun J, Zhang D, Qiu S. 2006. Controlled release of Captopril by regulating the pore size and morphology of ordered mesoporous silica. Micro Meso Mater 92: 1-9.
74. Radu DR, Lai CY, Wiench JW, Pruski M, Lin VSY. 2004. Gatekeeping layer effect: a poly(lactic acid)-coated mesoporous silica nanospherebased fluorescence probe for detection of amino-containing neurotransmitters. J Am Chem Soc 126: 1640-1641.
75. Radu DR, Lai CY, Jeftinija K, Rowe EW, Jeftinija S, Lin VS. 2004. A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent. J Am Chem Soc 126: 13216-13217.
76. Rosenholm JM, Peuhu E, Bate-Eya LT, Eriksson JE, Sahlgren C, Lindén M. 2010. Cancer-cell-specific induction of apoptosis using mesoporous silica nanoparticles as drug-delivery vectors. Small 6: 1234-1241.
77. Sadasivan S, Khushalani D, Mann S. 2003. Synthesis and shape modification of organo-functionalized silica nanoparticles with ordered mesostructured interiors. J Mater Chem 13: 1023-1029.
78. Schlossbauer A, Dohmen C, Schaffert D, Wagner E, Bein T. 2011. pH-responsive release of acetal-linked melittin from SBA-15 mesoporous silica. Angew Chem Int Ed Engl 50: 6828-6830.
79. Serre C, Millange F, Thouvenot C, Nogues M, Marsolier G, Louer D, Ferey G. 2002. Very large breathing effect in the first nanoporous chromium(III)-based solids: MIL-53 or CrIII(OH)·{O2C-C6H4-CO2}·{HO2C-C6H4-CO2H} x·H2Oy. J Am Chem Soc 124: 13519-13526.
80. Slowing I, Trewyn BG, Lin VS. 2006. Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells. J Am Chem Soc 128: 14792-14793.
81. Slowing II, Vivero-Escoto JL, Wu CW, Lin VS. 2008. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev 60: 1278-1288.
82. Slowing II, Trewyn BG, Lin VS. 2007. Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins. J Am Chem Soc 129: 8845-8849.
83. Slowing II, Vivero-Escoto JL, Wu CW, Lin VS. 2008. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev 60: 1278-1288.
84. Stucky GD, Monnier A, Schüth F, Huo Q, Margolese D, Kumar D, Krishnamurty M et al. 1994. Formation of novel oriented transparent films of layered silica-surfactant nanocomposite. Mol Cryst Liq Cryst 240: 187.
85. Tao Z, Morrow MP, Asefa T, Sharma KK, Duncan C, Anan A, Penefsky HS, Goodisman J, Souid AK. 2008. Mesoporous silica nanoparticles inhibit cellular respiration. Nano Lett 8: 1517-1526.
86. Tao Z, Toms BB, Goodisman J, Asefa T. 2009. Mesoporosity and functional group dependent endocytosis and cytotoxicity of silica nanomaterials. Chem Res Toxicol 22: 1869-1880.
87. Torney F, Trewyn BG, Lin VS, Wang K. 2007. Mesoporous silica nanoparticles deliver DNA and chemicals into plants. Nat Nanotechnol 2: 295-300.
88. Trewyn BG, Giri S, Slowing II, Lin VS. 2007. Mesoporous silica nanoparticle based controlled release, drug delivery, and biosensor systems. Chem Commun (Camb): 3236-3245.
89. Trewyn BG, Nieweg JA, Zhao Y, Lin VSY. 2008. Biocompatible mesoporous silica nanoparticles with different morphologies for animal cell membrane penetration. Chem Eng J 137: 23-29.
90. Trewyn BG, Slowing II, Giri S, Chen H, Lin VSY. 2007. Synthesis and functionalization of a mesoporous silica nanoparticle based on the sol-gel process and applications in controlled release. Acc Chem Res 40: 846-853.
91. Tsai CH, Vivero-Escoto JL, Slowing II, Fang IJ, Trewyn BG, Lin VS. 2011. Surfactant-assisted controlled release of hydrophobic drugs using anionic surfactant templated mesoporous silica nanoparticles. Biomaterials 32: 6234-6244.
92. Vallet-Regi M. 2001. Ceramics for medical applications. perspective article. J Chem Soc Dalton Trans 2: 97-108.
93. Vallet-Regi M. 2006. Synthesis and in vitro bioactivity of novel mesoporous hollow bioactive glass microspheres. Eur J Chem 12: 5934.
94. Vallet-Regi M, Arcos D. 2006. Nanostructured hybrid materials for bone tissue regeneration. Current Nanosci 2: 179-189.
95. Vallet-Regí M, Balas F, Arcos D. 2007. Mesoporous materials for drug delivery. Angew Chem Int Ed Engl 46: 7548-7558.
96. Vallet-Regi M, Doadrio JC, Doadrio AL, Barba II, Pariente JP. 2004. Hexagonal ordered mesoporous material as a matrix for the controlled release of Amoxicillin. Solid State Ionics 172: 435-439.
97. Vallet-Regi M, Rámila A, Del Real RP et al. 2001. A new property of MCM-41: drug delivery system. Chem Mater 13: 308-311.
98. Vivero-Escoto JL, Slowing II, Lin VS. 2010. Tuning the cellular uptake and cytotoxicity properties of oligonucleotide intercalator-functionalized mesoporous silica nanoparticles with human cervical cancer cells HeLa. Biomaterials 31: 1325-1333.
99. Vivero-Escoto JL, Slowing II, Trewyn BG, Lin VSY. 2009. Mesoporous silica nanoparticle-based double drug delivery system for glucoseresponsive controlled release of insulin and cyclic AMP. J Am Chem Soc 131: 8398-8400.
100. Voegtlin AC, Ruch F, Guth JL, Huve PJ. 1997. F-mediated synthesis of mesoporous silica with ionic and non ionic surfactants: A new templating pathway L. Micro Mater 9: 95.
101. Wang F, Gao F, Lan M, Yuan H, Huang Y, Liu J. 2009. Oxidative stress contributes to silica nanoparticle-induced cytotoxicity in human embryonic kidney cells. Toxicol In Vitro 23: 808-815.
102. Willam III RO, Vaughn JM. 2007. Nanoparticle engineering. Encycl Pharm Technol 4: 1170.
103. Wu P, Shao Q, Hu Y et al. 2010. Direct electrochemistry of glucose oxidase assembled on graphene and application to glucose detection. Electrochimica Acta 55:8606-8614.
104. Xu L, Zhu Y, Li Y et al. 2008. Bienzymatic glucose biosensor based on co-immobilization of glucose oxidase and horseradish peroxidase on gold nanoparticles-mesoporous silica matrix. Nanoelectronics Conference 2nd IEEE Int: 390-393.
105. Yan J, Estévez MC, Smith JE, Wang K, He X, Wang L, Tan W. 2007. Dye doped nanoparticles for bioanalysis. Nanotoday 2: 44-50.
106. Yang Y, Yan X, Cui Y, He Q, Li D, Wang A, Fei J, Li J. 2008. Preparation of polymer-coated mesoporous silica nanoparticles used for cellular imaging by a "graft-from" method. J Mater Chem 18: 5731-5737.
107. Zhang J, Li X, Rosenholm JM, Gu H-C. 2011. Synthesis and characterization of pore size-tunable magnetic mesoporous silica nanoparticles. J Colloid Int Sci 361: 16-24.
108. Zhang JJ, Zhu JJ. 2009. A novel amperometric biosensor based on gold nanoparticles-mesoporous silica composite for biosensing glucose. Science in China Series B: Chem 52: 815-820.
109. Zhang L, Qiao S, Jin Y, Yang H, Budihartono S, Stahr F, Yan Z, Wang X, Hao Z, Lu GQ. 2008. Fabrication and Size-Selective Bioseparation of Magnetic Silica Nanospheres with Highly Ordered Periodic Mesostructure. Adv. Funct. Mater 18: 3203-3212.
110. Zhao D, Huo Q, Feng J, Chmelka BF, Stucky GD. 1998. Nonionic triblock and star diblock copolymer and oligomeric surfactant syntheses of highly ordered, hydrothermally stable, mesoporous silica structures. J Am Chem Soc 120: 6024-6036.
111. Zhao D, Feng J, Huo Q, Melosh N, Fredrickson GH, Chmelka BF, Stucky GD. 1998. Triblock copolymer syntheses of mesoporous silica with periodic 50 to 300 angstrom pores. Science 279: 548-552.
112. Zhao W, Li Q. 2003. Synthesis of nanosize mcm-48 with high thermal stability. Chem Mater 15: 4160-4162.
113. Zhao Y, Sun X, Zhang G, Trewyn BG, Slowing II, Lin VS. 2011. Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects. ACS Nano 5: 1366-1375.
114. Zhao Y, Trewyn BG, Slowing II, Lin VS. 2009. Mesoporous silica nanoparticle-based double drug delivery system for glucoseresponsive controlled release of insulin and cyclic AMP. J Am Chem Soc 131: 8398-8400.